Jie Ni
About
In The Last Decade
Jie Ni
211 papers receiving 8.4k citations
Hit Papers
Peers
Comparison fields: 5 of 157
- Molecular Biology 3.4k
- Materials Chemistry 2.4k
- Cancer Research 1.7k
- Oncology 1.2k
- Pulmonary and Respiratory Medicine 1.0k
Countries citing papers authored by Jie Ni
This map shows the geographic impact of Jie Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Ni more than expected).
Fields of papers citing papers by Jie Ni
This network shows the impact of papers produced by Jie Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Ni. The network helps show where Jie Ni may publish in the future.
Co-authorship network of co-authors of Jie Ni
This figure shows the co-authorship network connecting the top 25 collaborators of Jie Ni. A scholar is included among the top collaborators of Jie Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jie Ni. Jie Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 4 | |
| 7 | 3 | |
| 8 | 8 | |
| 9 | 12 | |
| 10 | 11 | |
| 11 | 26 | |
| 12 | 1 | |
| 13 | 15 | |
| 14 | 14 | |
| 15 | 316 | |
| 16 | Inhibition of integrin-linked kinase by angiotensin II receptor antagonist, irbesartan attenuates podocyte injury in diabetic rats. | 12 |
| 17 | 40 | |
| 18 | Research on the Promotion of Recycling of Expired Drugs Based on the Game between the Government and the Pharmaceutical Retail Enterprises | 2 |
| 19 | 2 | |
| 20 | The new technology--smart well completion | 0 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.